May 22, 2025
Co-Founder Keynotes on Value-Added Medicines and Sponsors Industry Conferences
On May 22, 2025, IPDataLab joined ChinaPharma 2025, where Co-Founder Ms. Miao Li delivered a keynote at the Value-Added Medicines (VAMs) Forum: “Value-Added Medicines Going Global: Opportunities and Challenges.” Also sponsoring the 2025 China Pharmaceutical Industry Technology Conference and Green Development Conference, IPDataLab showcased its commitment to advancing innovation and sustainability in pharma.
Ms. Miao Li’s speech started with the transformative potential of Saudi Arabia's Vision 2030, which is driving a vibrant healthcare revolution in the MENA region. For Chinese pharmaceutical companies, this is a critical window to elevate global strategies by prioritizing innovation and addressing unmet clinical needs in the region. In a roundtable, she highlighted VAMs as vital incremental innovations that boost competitiveness and patient value, complementing rare breakthroughs.
IPDataLab empowers pharma companies with strategic intelligence for emerging markets, thereby navigating and overcoming regulatory and access challenges.